Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
333.28
+0.77 (+0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
39
40
Next >
These 8 Dow Jones Stocks Are Negative For 2021
December 30, 2021
The Dow Jones Industrial Average is a price-weighted index consisting of 30 stocks. It's one of the oldest and best-known measures of stock market performance. The blue-...
Via
Benzinga
Best Stocks For Wheel Strategy Trades: Use These In 2022
December 26, 2021
Blue chips companies, high dividend stocks, REITs, and low beta ETFs work well when employing the wheel strategy.
Via
Talk Markets
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
December 22, 2021
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.
Via
InvestorPlace
Expert Ratings For Amgen
December 21, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level
December 21, 2021
The FDA has approved Amgen Inc's (NASDAQ: AMGN) Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or...
Via
Benzinga
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
December 20, 2021
Senti Biosciences Inc, the synthetic biology play helmed by MIT whiz Tim Lu, will be merging with Farokhzad's Dynamics Special Purpose Corp (NASDAQ: DYNS) in a ...
Via
Benzinga
AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma
December 20, 2021
The FDA has approved AstraZeneca plc (NASDAQ: AZN) / Amgen Inc's (NASDAQ: AMGN) Tezspire (tezepelumab-ekko) as add-on maintenance treatment of adult...
Via
Benzinga
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some...
Via
Talk Markets
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also...
Via
Benzinga
Up More Than 750%, This Stock Just Increased Its Dividend Again
December 17, 2021
Dividend growth investing is like the gift that keeps on giving. Except it's better than that. It's the gift that keeps giving more... and more... and more.
Via
Talk Markets
Check Out What Whales Are Doing With AMGN
December 16, 2021
Someone with a lot of money to spend has taken a bearish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Photo by Hal Gatewood on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
2 Top Dividend Stocks That Just Hiked Their Payouts by 10% or More
December 13, 2021
And there could be even more increases in the future.
Via
The Motley Fool
5 Dividend Growth Stocks Getting Crushed… Time To Buy?
December 11, 2021
We have a disconnect between business performance and stock performance. And we have a disconnect between individual stocks and the stock market. These disconnects could lead us to fantastic long-term...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
Via
Benzinga
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...
Via
Benzinga
Can-Fite Expects Data Readout From Late-Stage Psoriasis Study With Piclidenoson In Q1 2022
December 07, 2021
Can-Fite BioPharma Ltd (NYSE: CANF) announced that the last of approximately 400 psoriasis patients enrolled in its Phase 3 Comfort study is scheduled to complete a 16-week...
Via
Benzinga
What 8 Analyst Ratings Have To Say About Amgen
December 06, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:
Via
Benzinga
Time To Load Up? This Dividend Growth Stock Has Been Beat Down By 30%
December 06, 2021
Amgen is benefiting from a rising tide that is lifting all boats. Already, Amgen has increased its dividend for 11 consecutive years.
Via
Talk Markets
A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Up 2%
December 06, 2021
Pre-open movers U.S. stock futures traded mostly higher in early pre-market trade after the Nasdaq dropped close to 300 points in the previous session. Investors are awaiting...
Via
Benzinga
Exposures
Fossil Fuels
5 Stocks To Watch For December 6, 2021
December 06, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Science Applications International Corporation (NYSE: SAIC) to report quarterly earnings at $1.50...
Via
Benzinga
4 Top Nasdaq-100 Stocks To Buy In December
December 04, 2021
The tech-heavy Nasdaq 100 trended higher this week amid the uncertainties surrounding inflation and the emergence of the Omicron coronavirus variant. So, we believe these fundamentally sound Nasdaq 100...
Via
Talk Markets
Exposures
COVID-19
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...
Via
Benzinga
Exposures
COVID-19
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
Johnson & Johnson's (NYSE: JNJ) Janssen Biotech Inc has received FDA approval for Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with...
Via
Benzinga
Exposures
Product Safety
Amgen's Otezla Meets Primary Goal In Late-Stage Genital Psoriasis Study
December 02, 2021
Amgen Inc (NASDAQ: AMGN) announced topline results from the DISCREET trial Phase 3 trial of Otezla (apremilast) in adults with moderate to severe genital psoriasis...
Via
Benzinga
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Amgen: For Growth And Income Investors
November 29, 2021
Amgen focuses on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology, and inflammation.
Via
Talk Markets
Price Over Earnings Overview: Amgen
November 29, 2021
In the current market session, Amgen Inc. (NASDAQ:AMGN) is trading at $202.59, after a 0.75% gain. However, over the past month, the stock fell by 5.41%, and in the...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.